Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2016 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting

NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American...
May 04, 2016 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors

NORTHVALE, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Davis S. Caskey to...
April 12, 2016 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Changes to their Board of Directors

NORTHVALE, N.J., April 12, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Eugene Pfeifer to...
March 17, 2016 07:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA

NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM...
February 09, 2016 16:31 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016

NORTHVALE, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended December 31, 2015, the third quarter...
February 05, 2016 12:42 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016

NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
January 13, 2016 16:51 ET | Source: Elite Pharmaceuticals, Inc.

FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals

NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- The United State Food and Drug Administration (“FDA”) granted Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a waiver of the...
January 13, 2016 09:24 ET | Source: Elite Pharmaceuticals, Inc.

Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals

NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that Jerry Treppel has resigned as the Company’s Chairman and as a...
November 09, 2015 16:37 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016

NORTHVALE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second...
November 05, 2015 17:12 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015

Northvale, NJ, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of...